Table 2.
MCI adherents to prescribed dose of 6-month intervention | MCI | ANOVA | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Exer-tour | Exer-score | ANOVA | Combined adherents | Non-adherents | ||||||||||||
Ave | SD | n | Ave | SD | n | pa | Ave | SD | n | Ave | SD | n | pa | |||
PRIMARY OUTCOME | ||||||||||||||||
Baseline executive functiona | ||||||||||||||||
Color Trails | 0.49 | 0.17 | 7 | 0.47 | 0.10 | 7 | 0.85 | 0.48 | 0.13 | 14 | 0.48 | 0.21 | 54 | |||
Stroop A/C | 0.40 | 0.12 | 7 | 0.40 | 0.14 | 7 | 0.98 | 0.40 | 0.12 | 14 | 0.44 | 0.12 | 54 | |||
Digits B/F | 0.53 | 0.13 | 7 | 0.59 | 0.21 | 7 | 0.56 | 0.56 | 0.17 | 14 | 0.61 | 0.16 | 54 | |||
t-test | t-test | t-test | (grp × time)c | |||||||||||||
3-Month executive function | pb | pb | pb | P | ||||||||||||
Color Trails | 0.44 | 0.11 | 7 | 0.41 | 0.44 | 0.07 | 7 | 0.34 | 0.44 | 0.09 | 14 | 0.20 | 0.89 | |||
Stroop A/C | 0.45 | 0.06 | 7 | 0.25 | 0.41 | 0.15 | 7 | 0.68 | 0.43 | 0.11 | 14 | 0.21 | 0.46 | |||
Digits B/F | 0.53 | 0.23 | 7 | 0.97 | 0.61 | 0.12 | 7 | 0.65 | 0.57 | 0.18 | 14 | 0.77 | 0.93 | |||
6-Month executive function | ||||||||||||||||
Color Trails 1/2 | 0.38 | 0.12 | 6 | 0.10 | 0.48 | 0.17 | 7 | 0.83 | 0.44 | 0.15 | 13 | 0.32 | 0.11 | |||
Stroop A/C | 0.48 | 0.11 | 6 | 0.049 | 0.47 | 0.15 | 7 | 0.001 | 0.47 | 0.13 | 13 | 0.0002 | 0.82 | |||
Digits B/F | 0.60 | 0.15 | 6 | .38 | 0.64 | 0.16 | 7 | 0.50 | 0.62 | 0.15 | 13 | 0.26 | 0.99 |
Comparison between groups.
Comparison with baseline.
Repeated meas ANCOVA controlling for age and education.
Bold values indicates statistically significant (p ≤ 0.05).